Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

EBCC 2024

20–22 March 2024 | Milan, Italy

EBCC 2024

20–22 March 2024 | Milan, Italy
Drivers of surgical choice in breast cancer following neoadjuvant therapy 2:40
Drivers of surgical choice in breast cancer following neoadjuvant therapy
Federica Martorana • 25 Mar 2024
Avoiding unnecessary mastectomies in breast cancer 1:17
Avoiding unnecessary mastectomies in breast cancer
Federica Martorana • 25 Mar 2024
When is surgery needed before adjuvant therapy in breast cancer? 2:16
When is surgery needed before adjuvant therapy in breast cancer?
Isabel Rubio • 15 Mar 2024
Managing patients with breast cancer germline susceptibility 2:06
Managing patients with breast cancer germline susceptibility
Isabel Rubio • 15 Mar 2024
Axillary surgery trends in breast cancer after neoadjuvant treatment 1:34
Axillary surgery trends in breast cancer after neoadjuvant treatment
Isabel Rubio • 15 Mar 2024
Vacuum assisted biopsy instead of surgery in breast cancer 4:54
Vacuum assisted biopsy instead of surgery in breast cancer
Nisha Sharma • 19 Mar 2024
Artificial intelligence in breast cancer screening study 2:19
Artificial intelligence in breast cancer screening study
Nisha Sharma • 19 Mar 2024
The future of artificial intelligence in breast cancer screening 2:06
The future of artificial intelligence in breast cancer screening
Nisha Sharma • 19 Mar 2024
Partial and no radiation in elderly patients with breast cancer 2:11
Partial and no radiation in elderly patients with breast cancer
Icro Meattini • 21 Mar 2024
Omitting radiotherapy in the SINODAR-ONE protocol for breast cancer 1:34
Omitting radiotherapy in the SINODAR-ONE protocol for breast cancer
Ruggero Spoto • 15 Mar 2024
Impact of the SINODAR-ONE trial on clinical practice 1:08
Impact of the SINODAR-ONE trial on clinical practice
Ruggero Spoto • 15 Mar 2024
Potential advances in radiotherapy for breast cancer 1:05
Potential advances in radiotherapy for breast cancer
Ruggero Spoto • 15 Mar 2024
The case for neoadjuvant pembrolizumab in TNBC 1:42
The case for neoadjuvant pembrolizumab in TNBC
Jean-Yves Pierga • 22 Mar 2024
Immunotherapy biomarkers in neoadjuvant breast cancer 1:03
Immunotherapy biomarkers in neoadjuvant breast cancer
Jean-Yves Pierga • 22 Mar 2024
Assessing the utility of CTC count-driven therapy in breast cancer 2:02
Assessing the utility of CTC count-driven therapy in breast cancer
Jean-Yves Pierga • 22 Mar 2024
Second breast conserving surgery for small recurrence early disease 1:40
Second breast conserving surgery for small recurrence early disease
Jean-Michel Hannoun-Levi • 22 Mar 2024
The content of VJOncology is intended for healthcare professionals